Lineage Cell Therapeutics Provides End of Year Shareholder Letter

Go back to Lineage Cell Therapeutics Provides End of Year Shareholder Letter
(NYSE: LCTX) Delayed: 1.12 --0 (-0%)
Previous Close $1.12    52 Week High
Open $1.12    52 Week Low
Day High $1.12    P/E N/A 
Day Low $1.12    EPS
Volume 658       

(NYSE: LCTX) Delayed: 1.12 --0 (-0%)
Previous Close $1.12    52 Week High
Open $1.12    52 Week Low
Day High $1.12    P/E N/A 
Day Low $1.12    EPS
Volume 658